Where does Mitralign, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Mitralign, Inc. ranks #11,735 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Mitralign, Inc. hold?

Mitralign, Inc. holds 26 US utility patents granted between 2015 and 2019, spanning 3 technology areas.

What is Mitralign, Inc.'s Innovation Score?

Mitralign, Inc. has an Innovation Score of 28.1 out of 100 (26th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Mitralign, Inc. focus on?

Mitralign, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 25 patents, ranking #733 of 7,127 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Mitralign, Inc.'s patent grant rate increasing or decreasing?

Mitralign, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Mitralign, Inc.'s patents?

Mitralign, Inc.'s patents average 17.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Mitralign, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Mitralign, Inc.

USPTO PatentsView assignee record - 26 granted patents across 3 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Mitralign ranks #11,735 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 3 technology areas.

#11,735
of 49,997 US assignees by volume: 26th percentile
by Innovation Score (28.1/100): 17.6
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11735 · US Corporation #11,735 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 26 grants
UPPER-Q #11,735/49,997
PHOTO-FINISH Macom Connectivity…
CPC-NARROW A61B · 3 areas
INNOV-THIN 28.1/100
CLAIMS-RICH 17.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Macom Connectivity Solutions, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Mitralign’s 28.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.4 pts (41%) Velocity 0.0 pts (0%) Breadth 6.1 pts (22%) Claim depth 10.5 pts (38%)

Qualcomm Incorporated · highest

85
Green Extraction · near

28
Nextronics Engineering · near

28
Lisle · near

28
Mitralign · this assignee

28
Nsk-warner K K · near

28
3D Lighting… · lowest

7

What this shows Mitralign's Innovation Score is 28.1/100 (26th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Mitralign?

Each dot is one of Mitralign’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mitralign’s own 17.6 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Mitralign vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Mitralign's grants concentrate

Mitralign, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 96.2% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (9 grants) versus a trough of 1 in 2019. By volume, Mitralign sits between Macom Connectivity Solutions, LLC and Mad Apparel, Inc..

Macom Connectivit…

26
MAS Innovation (P…

26
Mesoblast

26
Millennial Media

26
Mitsubishi Plasti…

26
MOJ IO

26
Motionpoint

26
Mad Apparel

26
Mitralign ◀

26

What this shows Mitralign holds 26 patents at rank #11,728, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Mitralign

By rank, the assignees closest to #11,728 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Mitralign's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Mitralign, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Mitralign ranks #733 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (28 here).

Nsk-warner K.K. 28 Lisle Corporation 28 Nextronics Engineering Corp. 28 Green Extraction Technologies 28

Mitralign's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 26th percentile higher than 26% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Mitralign, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	34.6%
2016	4	15.4%
2017	6	23.1%
2018	6	23.1%
2019	1	3.8%

Which technologies does Mitralign, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 25

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 18

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Mitralign, Inc.'s patent record in context - here's where to go next.

Mitralign, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 96.2% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #11,735 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Mitralign, Inc. against Macom Connectivity Solutions, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.